Filing Flows › Biotricity (BTCY) › Q1 FY26
Biotricity (BTCY) Q1 FY26 earnings results (first quarter fiscal 2026)
10-Q filed Aug 14, 2025
Biotricity (BTCY) reported revenue of $3.9M for the first quarter fiscal 2026 (Q1 FY26), +21% from a year earlier and +5% from the quarter before. Operating margin was 7.3%, net loss $672K (17.3% of revenue).
Biotricity, Q1 FY26: revenue $3.9M (+21% year over year), operating margin 7.3%, net loss $672K, operating cash flow −$373K. The chart follows the revenue to costs, profit and cash.
| Q1 FY26 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $3.9M | +5% | +21% |
| Operating profit | $282K | — | — |
| Net earnings | −$672K | — | — |
| Operating cash flow | −$373K | — | — |
What changed
Revenue was $3.9M in Q1 FY26, up 21% year over year and up 5% from the previous quarter. Technology Fees was the largest line at 87% of revenue. Technology Fees added $355K year over year (up 12%), 53% of the total change.
Gross margin was 80.5%, up 6.6 points from a year earlier. Operating profit was $282K, a 7.3% margin (up 42.2 points year over year). Operating expenses fell 19% while revenue rose 21%. The fastest-growing cost line was Research & development (+35%). The quarter ended with a net loss of $672K, narrower than the previous quarter's $1.9M loss. Net interest and other expense of $1.0M was the main reason.
Operating cash flow was −$373K. Non-cash charges added back $1K of depreciation and $6K of share-based compensation. Working capital and other items added $291K.
Questions
What was Biotricity's revenue in the first quarter fiscal 2026?
Biotricity (BTCY) reported revenue of $3.9M for the first quarter fiscal 2026 (Q1 FY26), +21% from a year earlier and +5% from the quarter before.
Was Biotricity profitable in the first quarter fiscal 2026?
Operating profit was $282K (7.3% of revenue) and net loss $672K.
Source: Biotricity 10-Q on SEC EDGAR.